We also find that TRIM25 expression is positively correlated with TP53 mutation in the human cancers including HCC and breast cancer (Supplementary Fig. 6g, h), implying that the increased expression of TRIM25 in cancer may be in part due to TP53 inactivating mutations. This evidence concerns the gene TP53 and breast carcinoma.